Today, the proposed combination of the legacy companies Novozymes and Chr. Hansen is successfully completed, establishing the company Novonesis. Novonesis.
Health Canada has authorized functional claims that Chr Hansen’s probiotic DDS-1 strain, “helps alleviate perceived stress and improve irritable bowel syndrome-related quality of life in adolescents and adults”.